GENPHARMASEC
Back to Balance Sheet
|
GENPHARMASEC Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | |
|---|---|---|---|
| Total Current Liabilities | ₹9.84 Cr | ₹2.70 Cr | ₹2.06 Cr |
What is the latest Total Current Liabilities ratio of GENPHARMASEC ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹9.84 Cr |
| Mar2024 | ₹2.70 Cr |
| Mar2023 | ₹2.06 Cr |
How is Total Current Liabilities of GENPHARMASEC Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹9.84 Cr | 264.03 | |
| Mar2024 | ₹2.70 Cr | 30.91 | |
| Mar2023 | ₹2.06 Cr | - | |
Compare Total Current Liabilities of peers of GENPHARMASEC
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GENPHARMASEC | ₹73.6 Cr | -2.3% | NA | -42.9% | Stock Analytics | |
| SUDARSHAN CHEMICAL INDUSTRIES | ₹7,073.5 Cr | -1.6% | 0.5% | 0.8% | Stock Analytics | |
| KIRI INDUSTRIES | ₹2,740.3 Cr | 1.1% | -5.5% | -16% | Stock Analytics | |
| VIDHI SPECIALTY FOOD INGREDIENTS | ₹1,541.6 Cr | -2.2% | -1.5% | -30.7% | Stock Analytics | |
| SHREE PUSHKAR CHEMICALS & FERTILISERS | ₹1,032.1 Cr | -4.9% | -4.7% | 13.4% | Stock Analytics | |
| BODAL CHEMICALS | ₹595.1 Cr | 0.1% | 1.7% | -21.5% | Stock Analytics | |
GENPHARMASEC Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GENPHARMASEC | -2.3% |
NA |
-42.9% |
| SENSEX | 0.2% |
1.1% |
8.8% |
You may also like the below Video Courses